ResMed Astral 100/150 Ventilators Recalled Due to Electrolyte Leakage Risk
ResMed is recalling Astral 100/150 ventilators because supercapacitor electrolyte leakage can damage the charger chip, trigger a fail-safe state, and interrupt ventilation therapy.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA classified this recall as Class I, which under the rubric corresponds to a reasonable probability of serious adverse health consequences or death. Therefore the severity score is 5 (Critical).
Plain-English summary
ResMed is recalling its Astral 100 and Astral 150 ventilators, which provide continuous or intermittent ventilatory support for patients weighing more than 11 lb (5 kg) who require mechanical ventilation. The recall covers 168,069 devices globally, and the FDA has classified it as a Class I recall.
The recall was issued because supercapacitor electrolyte leakage on the printed circuit board assembly (PCBA) can damage the charger chip. This damage may cause the ventilator to enter a fail-safe state and interrupt ventilation therapy.
The affected devices were distributed nationwide in the United States and in many countries worldwide. The recall notice includes specific UDI-DI codes and serial-number ranges for identifying affected ventilators and spare parts.
Patients, caregivers, and providers should check the FDA recall notice to determine whether their device is affected and follow the instructions in the notice.
The recalled product
- Product
- Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for patients weighing more than 11lb (5kg) who require mechanical ventilation.
- Manufacturer
- ResMed Ltd.
- Affected units
- 168,069
Distribution
Related recalls
Same manufacturer · ResMed Ltd.
See all →- SevereAirTouch F20 Full Face Mask Recalled for Magnetic Interference with Medical Implants
FDA (Devices) · 2023-12-27
- SevereAirFit F20 Full Face Mask recalled for magnetic interference with medical implants
FDA (Devices) · 2023-12-27
- SevereAirTouch N20 Nasal Mask recalled for magnetic interference with medical implants
FDA (Devices) · 2023-12-27
- SevereResMed AirFit N10 Nasal Masks Recalled for Magnetic Interference with Medical Implants
FDA (Devices) · 2023-12-27
- SevereAirFit F30i Full Face Mask Recalled Due to Magnetic Interference Risk
FDA (Devices) · 2023-12-27
Similar recalls
- SevereResMed Astral Ventilator Recall Due to Alarm Disabling Hazard
FDA (Devices) · 2015-06-17
- SevereResMed Astral ventilators recalled for power loss and failed alarms
FDA (Devices) · 2023-11-01
- HighResmed Recalls Astral 100 and 150 External Batteries Due to Start-Up Issue
FDA (Devices) · 2016-02-10
- SevereResMed Stellar Ventilators Recalled for Potential Alarm Failure
FDA (Devices) · 2020-02-12
- SeverePhillips Respironics Recalls Trilogy Ventilators Due to Power Board Defect
FDA (Devices) · 2014-03-12
- SevereRespironics Trilogy Ventilators Recalled for Faulty Power Supply Component
FDA (Devices) · 2012-08-01